Cargando…

Lactoferrin: neuroprotection against Parkinson's disease and secondary molecule for potential treatment

Parkinson's disease (PD) is the second-most common neurodegenerative disease and is largely caused by the death of dopaminergic (DA) cells. Dopamine loss occurs in the substantia nigra pars compacta and leads to dysfunctions in motor functions. Death of DA cells can occur with oxidative stress...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eker, Furkan, Bolat, Ecem, Pekdemir, Burcu, Duman, Hatice, Karav, Sercan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508234/ https://www.ncbi.nlm.nih.gov/pubmed/37731953 http://dx.doi.org/10.3389/fnagi.2023.1204149

Ejemplares similares

Lactoferrin for COVID-19 prevention, treatment, and recovery
por: Bolat, Ecem, et al.
Publicado: (2022)

Role of milk glycome in prevention, treatment, and recovery of COVID-19
por: Kaplan, Merve, et al.
Publicado: (2022)

Bovine colostrum and its potential contributions for treatment and prevention of COVID-19
por: Duman, Hatice, et al.
Publicado: (2023)

Studying Lactoferrin N-Glycosylation
por: Karav, Sercan, et al.
Publicado: (2017)

The potential neuroprotective effects of stingless bee honey
por: Zulkifli, Nurdarina Ausi, et al.
Publicado: (2023)

Immobilization of a Bifidobacterial Endo-ß-N-Acetylglucosaminidase to Generate Bioactive Compounds for Food Industry
por: Pekdemir, Burcu, et al.
Publicado: (2022)

Structural insights of two novel N-acetyl-glucosaminidase enzymes through in silico methods
por: ŞAHUTOĞLU, Arif Sercan, et al.
Publicado: (2020)

Potential roles of oxidative distress on neurodegeneration in Parkinson's disease with neuropsychiatric symptoms
por: Li, Dan-ning, et al.
Publicado: (2022)

Exploring therapeutic potential of mitophagy modulators using Drosophila models of Parkinson’s disease
por: Asthana, Jyotsna, et al.
Publicado: (2022)

Characterization of recombinant human lactoferrin N-glycans expressed in the milk of transgenic cows
por: Parc, Annabelle Le, et al.
Publicado: (2017)

Neuroprotective effect of Dl-3-n-butylphthalide against ischemia–reperfusion injury is mediated by ferroptosis regulation via the SLC7A11/GSH/GPX4 pathway and the attenuation of blood–brain barrier disruption
por: Xu, Shuangli, et al.
Publicado: (2023)

The role of microglial autophagy in Parkinson’s disease
por: Zhu, Rui, et al.
Publicado: (2022)

A Roadmap for Future Parkinson's Pharmacogenomics in Asia
por: Akbar, Muhammad, et al.
Publicado: (2022)

Impact of aging on animal models of Parkinson's disease
por: Klæstrup, Ida Hyllen, et al.
Publicado: (2022)

Editorial: Genetic and molecular diversity in Parkinson's disease
por: Abdul Murad, Nor Azian, et al.
Publicado: (2022)

Oculomotor impairments in de novo Parkinson’s disease
por: Zhou, Meng-Xi, et al.
Publicado: (2022)

Microglial autophagy in Alzheimer’s disease and Parkinson’s disease
por: Wang, Zhifu, et al.
Publicado: (2023)

Precision medicine for Parkinson’s disease: The subtyping challenge
por: Frasier, Mark, et al.
Publicado: (2022)

Small-molecule drugs development for Alzheimer's disease
por: Yao, Weiwei, et al.
Publicado: (2022)

Neuroprotective effect of angiotensin II receptor blockers on the risk of incident Alzheimer’s disease: A nationwide population-based cohort study
por: Lee, Hyun Woo, et al.
Publicado: (2023)

Peripheral Clock System Abnormalities in Patients With Parkinson’s Disease
por: Li, Tianbai, et al.
Publicado: (2021)

The Disease Modification Conundrum in Parkinson’s Disease: Failures and Hopes
por: Mari, Zoltan, et al.
Publicado: (2022)

New Understanding on the Pathophysiology and Treatment of Constipation in Parkinson’s Disease
por: Xu, Jianli, et al.
Publicado: (2022)

Genetic analysis of dystonia-related genes in Parkinson's disease
por: Wang, Yige, et al.
Publicado: (2023)

Concomitant protein pathogenesis in Parkinson’s disease and perspective mechanisms
por: Han, Yuliang, et al.
Publicado: (2023)

Identifying prodromal symptoms at high specificity for Parkinson’s disease
por: Jackson, Holly, et al.
Publicado: (2023)

Changes in smoking, alcohol consumption, and the risk of Parkinson’s disease
por: Jung, Se Young, et al.
Publicado: (2023)

Reducing the receipt of contraindicated medications in patients with Parkinson disease
por: Goldin, Caroline, et al.
Publicado: (2023)

Unique characteristics of end-of-life hospitalizations in Parkinson disease
por: Aamodt, Whitley W., et al.
Publicado: (2023)

Iron accumulation in the ventral tegmental area in Parkinson's disease
por: Zhang, Dongling, et al.
Publicado: (2023)

The interaction of peptide inhibitors and Aβ protein: Binding mode analysis, inhibition of the formation of Aβ aggregates, and then exert neuroprotective effects
por: Wu, Yuchen, et al.
Publicado: (2023)

Serum zinc deficiency is a potential risk factor for the occurrence of levodopa-induced dyskinesia in drug-naïve Parkinson’s disease
por: Kim, Joung Eun, et al.
Publicado: (2023)

Sex Differences in Brain and Cognition in de novo Parkinson's Disease
por: Oltra, Javier, et al.
Publicado: (2022)

Clinical Characteristics of Minor Hallucinations in Chinese Parkinson's Disease Patients
por: Zhang, Yu, et al.
Publicado: (2022)

Factors Contributing to the Severity and Laterality of Pisa Syndrome in Parkinson’s Disease
por: Huh, Young Eun, et al.
Publicado: (2022)

Editorial: Translational Advances in Alzheimer's, Parkinson's, and Other Neurodegenerative Dementias
por: Jiang, Jiehui, et al.
Publicado: (2022)

Nilotinib in Parkinson's disease: A systematic review and meta-analysis
por: Xie, Xiaolu, et al.
Publicado: (2022)

Recognition of Freezing of Gait in Parkinson’s Disease Based on Machine Vision
por: Li, Wendan, et al.
Publicado: (2022)

Structural Brain Network Abnormalities in Parkinson’s Disease With Freezing of Gait
por: Jin, Chaoyang, et al.
Publicado: (2022)

Morphologic brain network predicts levodopa responsiveness in Parkinson disease
por: Xie, Yongsheng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0ofb6mie3dpsvjjlvesdrue5ni